View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 9, 2022

Adaptive Research and UBERDOC to extend patient access to clinical studies

Under the partnership, Adaptive Research will obtain access to UBERDOC’s clinics and hospitals to carry out a trial.

Adaptive Research and UBERDOC have partnered to extend access to clinical trials to the physicians, patients and study sites in the latter’s network.

Through the alliance, Adaptive Research will gain access to UBERDOC physicians who are eligible to become trial investigators. 

In addition, Adaptive Research will be able to access UBERDOC clinics and hospitals, as well as institutions that have the required staff and amenities to carry out a trial.

Under the collaboration, UBERDOC could provide clinical trial opportunities of Adaptive Research to more than 3,000 board-certified physicians and experts in their network. 

Adaptive Research provides a variety of solutions to pharmaceutical firms and clinical research organisations (CROs) for boosting recruitment in clinical trials.

These firms will now get access to patients using UBERDOC’s physician network.

Adaptive Research president and CEO Deepak Behera said: “UBERDOC’s mission to decentralise the healthcare treatment landscape perfectly synergises with our goal to bring clinical trials to the broader community. 

“We look forward to working together to generate greater access to clinical trials and provide a path to market for groundbreaking medical products.”

An integrated clinical trial site organisation, Adaptive Research focuses on democratising clinical trials by leveraging digital technologies and incorporating community physicians into the trial process.

UBERDOC CEO and founder Paula Muto said: “As the leading direct-to-consumer digital healthcare platform, we are committed to connecting physicians and patients with the care they need. 

“This partnership with Adaptive Research will alert our physician network of certain clinical trials and give them the support to participate in the trial.”

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU